Doug Schenkel
Stock Analyst at Wolfe Research
(3.59)
# 604
Out of 4,829 analysts
66
Total ratings
52.08%
Success rate
33.81%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Initiates: Outperform | $60 | $62.69 | -4.29% | 1 | Dec 13, 2024 | |
| HOLX Hologic | Initiates: Peer Perform | n/a | $58.81 | - | 5 | Dec 13, 2024 | |
| TWST Twist Bioscience | Initiates: Outperform | $60 | $32.95 | +82.09% | 2 | Dec 13, 2024 | |
| STVN Stevanato Group | Initiates: Outperform | $28 | $23.66 | +18.34% | 1 | Dec 13, 2024 | |
| WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $219.46 | - | 1 | Dec 13, 2024 | |
| RGEN Repligen | Initiates: Peer Perform | n/a | $133.72 | - | 1 | Nov 14, 2024 | |
| MRVI Maravai LifeSciences Holdings | Initiates: Peer Perform | n/a | $2.12 | - | 1 | Nov 14, 2024 | |
| DHR Danaher | Upgrades: Outperform | $285 | $200.83 | +41.91% | 2 | Oct 31, 2024 | |
| BRKR Bruker | Downgrades: Peer Perform | n/a | $40.26 | - | 2 | Sep 30, 2024 | |
| A Agilent Technologies | Downgrades: Peer Perform | n/a | $115.55 | - | 8 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $52 | $42.96 | +19.88% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $9.49 | - | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $81.57 | - | 5 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $53.40 | - | 4 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $432.59 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.25 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $98.50 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $1.10 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $13.00 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $41.66 | - | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $157.29 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $366.67 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.19 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $2.93 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.32 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.73 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.89 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.46 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $2.63 | +584.41% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $23.45 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $316.67 | -71.58% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.73 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $217.23 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $85.05 | -81.19% | 2 | Sep 28, 2017 |
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $62.69
Upside: -4.29%
Hologic
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $58.81
Upside: -
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $32.95
Upside: +82.09%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $23.66
Upside: +18.34%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $219.46
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $133.72
Upside: -
Maravai LifeSciences Holdings
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $2.12
Upside: -
Danaher
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $200.83
Upside: +41.91%
Bruker
Sep 30, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $40.26
Upside: -
Agilent Technologies
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $115.55
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $52
Current: $42.96
Upside: +19.88%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $9.49
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $81.57
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $53.40
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $432.59
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $4.25
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $98.50
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $1.10
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $13.00
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $41.66
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $157.29
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $366.67
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.19
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $2.93
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $2.32
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $5.73
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.89
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $2.46
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $2.63
Upside: +584.41%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $23.45
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $316.67
Upside: -71.58%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $5.73
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $217.23
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $85.05
Upside: -81.19%